vs

Side-by-side financial comparison of FVCBankcorp, Inc. (FVCB) and OptimizeRx Corp (OPRX). Click either name above to swap in a different company.

OptimizeRx Corp is the larger business by last-quarter revenue ($32.2M vs $16.9M, roughly 1.9× FVCBankcorp, Inc.). On growth, FVCBankcorp, Inc. posted the faster year-over-year revenue change (4377.5% vs -0.2%). FVCBankcorp, Inc. produced more free cash flow last quarter ($23.8M vs $7.1M). Over the past eight quarters, FVCBankcorp, Inc.'s revenue compounded faster (586.6% CAGR vs 28.0%).

FVCBankcorp, Inc. is a Virginia-based U.S. bank holding company operating FVCbank, a community-focused financial institution. It provides a full range of personal and commercial banking products including deposit accounts, business and personal loans, mortgage services, and wealth management solutions, serving SMEs, professionals and individual consumers across the Mid-Atlantic region.

OptimizeRx Corp is a U.S.-headquartered digital health technology company that delivers patient engagement, medication affordability and clinical communication solutions to life sciences enterprises, healthcare providers and pharmacy partners. Its core offerings include digital medication savings tools, patient support programs, and therapeutic area-specific resources to boost medication access and treatment adherence.

FVCB vs OPRX — Head-to-Head

Bigger by revenue
OPRX
OPRX
1.9× larger
OPRX
$32.2M
$16.9M
FVCB
Growing faster (revenue YoY)
FVCB
FVCB
+4377.8% gap
FVCB
4377.5%
-0.2%
OPRX
More free cash flow
FVCB
FVCB
$16.7M more FCF
FVCB
$23.8M
$7.1M
OPRX
Faster 2-yr revenue CAGR
FVCB
FVCB
Annualised
FVCB
586.6%
28.0%
OPRX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FVCB
FVCB
OPRX
OPRX
Revenue
$16.9M
$32.2M
Net Profit
$5.0M
Gross Margin
74.8%
Operating Margin
43.7%
26.6%
Net Margin
15.6%
Revenue YoY
4377.5%
-0.2%
Net Profit YoY
6535.9%
EPS (diluted)
$0.31
$0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FVCB
FVCB
OPRX
OPRX
Q4 25
$16.9M
$32.2M
Q3 25
$416.0K
$26.1M
Q2 25
$15.8M
$29.2M
Q1 25
$382.0K
$21.9M
Q4 24
$378.0K
$32.3M
Q3 24
$412.0K
$21.3M
Q2 24
$415.0K
$18.8M
Q1 24
$359.0K
$19.7M
Net Profit
FVCB
FVCB
OPRX
OPRX
Q4 25
$5.0M
Q3 25
$5.6M
$779.0K
Q2 25
$5.7M
$1.5M
Q1 25
$5.2M
$-2.2M
Q4 24
$-78.0K
Q3 24
$4.7M
$-9.1M
Q2 24
$4.2M
$-4.0M
Q1 24
$1.3M
$-6.9M
Gross Margin
FVCB
FVCB
OPRX
OPRX
Q4 25
74.8%
Q3 25
67.2%
Q2 25
63.8%
Q1 25
60.9%
Q4 24
68.1%
Q3 24
63.1%
Q2 24
62.2%
Q1 24
62.0%
Operating Margin
FVCB
FVCB
OPRX
OPRX
Q4 25
43.7%
26.6%
Q3 25
7.9%
Q2 25
45.9%
10.9%
Q1 25
-9.6%
Q4 24
11.2%
Q3 24
-40.2%
Q2 24
-19.9%
Q1 24
-25.5%
Net Margin
FVCB
FVCB
OPRX
OPRX
Q4 25
15.6%
Q3 25
1341.1%
3.0%
Q2 25
36.0%
5.2%
Q1 25
1352.1%
-10.0%
Q4 24
-0.2%
Q3 24
1133.3%
-42.8%
Q2 24
1001.2%
-21.3%
Q1 24
373.3%
-35.0%
EPS (diluted)
FVCB
FVCB
OPRX
OPRX
Q4 25
$0.31
$0.27
Q3 25
$0.31
$0.04
Q2 25
$0.31
$0.08
Q1 25
$0.28
$-0.12
Q4 24
$0.27
$0.00
Q3 24
$0.25
$-0.50
Q2 24
$0.23
$-0.22
Q1 24
$0.07
$-0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FVCB
FVCB
OPRX
OPRX
Cash + ST InvestmentsLiquidity on hand
$23.4M
Total DebtLower is stronger
$26.3M
Stockholders' EquityBook value
$253.6M
$128.3M
Total Assets
$2.3B
$176.9M
Debt / EquityLower = less leverage
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FVCB
FVCB
OPRX
OPRX
Q4 25
$23.4M
Q3 25
$19.5M
Q2 25
$16.6M
Q1 25
$16.6M
Q4 24
$13.4M
Q3 24
$16.1M
Q2 24
Q1 24
Total Debt
FVCB
FVCB
OPRX
OPRX
Q4 25
$26.3M
Q3 25
$28.8M
Q2 25
$29.3M
Q1 25
$33.8M
Q4 24
$34.3M
Q3 24
$36.8M
Q2 24
$37.3M
Q1 24
$37.8M
Stockholders' Equity
FVCB
FVCB
OPRX
OPRX
Q4 25
$253.6M
$128.3M
Q3 25
$249.8M
$122.3M
Q2 25
$243.2M
$119.3M
Q1 25
$242.3M
$116.3M
Q4 24
$235.4M
$117.0M
Q3 24
$230.8M
$114.5M
Q2 24
$226.5M
$121.0M
Q1 24
$220.7M
$122.5M
Total Assets
FVCB
FVCB
OPRX
OPRX
Q4 25
$2.3B
$176.9M
Q3 25
$2.3B
$170.3M
Q2 25
$2.2B
$169.3M
Q1 25
$2.2B
$167.8M
Q4 24
$2.2B
$171.2M
Q3 24
$2.3B
$165.2M
Q2 24
$2.3B
$172.9M
Q1 24
$2.2B
$176.4M
Debt / Equity
FVCB
FVCB
OPRX
OPRX
Q4 25
0.20×
Q3 25
0.24×
Q2 25
0.25×
Q1 25
0.29×
Q4 24
0.29×
Q3 24
0.32×
Q2 24
0.31×
Q1 24
0.31×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FVCB
FVCB
OPRX
OPRX
Operating Cash FlowLast quarter
$23.9M
$7.1M
Free Cash FlowOCF − Capex
$23.8M
$7.1M
FCF MarginFCF / Revenue
140.7%
22.0%
Capex IntensityCapex / Revenue
0.3%
0.0%
Cash ConversionOCF / Net Profit
1.41×
TTM Free Cash FlowTrailing 4 quarters
$40.0M
$18.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FVCB
FVCB
OPRX
OPRX
Q4 25
$23.9M
$7.1M
Q3 25
$7.6M
$3.2M
Q2 25
$3.3M
$4.6M
Q1 25
$5.4M
$3.9M
Q4 24
$18.2M
$198.0K
Q3 24
$4.7M
$1.8M
Q2 24
$1.6M
$782.0K
Q1 24
$7.2M
$2.1M
Free Cash Flow
FVCB
FVCB
OPRX
OPRX
Q4 25
$23.8M
$7.1M
Q3 25
$7.6M
$3.2M
Q2 25
$3.3M
$4.6M
Q1 25
$5.4M
$3.8M
Q4 24
$18.1M
$181.0K
Q3 24
$4.6M
$1.8M
Q2 24
$1.5M
$737.0K
Q1 24
$7.1M
$2.1M
FCF Margin
FVCB
FVCB
OPRX
OPRX
Q4 25
140.7%
22.0%
Q3 25
1818.0%
12.2%
Q2 25
20.8%
15.6%
Q1 25
1413.6%
17.5%
Q4 24
4786.0%
0.6%
Q3 24
1121.8%
8.3%
Q2 24
361.2%
3.9%
Q1 24
1988.3%
10.6%
Capex Intensity
FVCB
FVCB
OPRX
OPRX
Q4 25
0.3%
0.0%
Q3 25
0.2%
0.0%
Q2 25
0.1%
0.0%
Q1 25
4.2%
0.1%
Q4 24
37.3%
0.1%
Q3 24
14.1%
0.1%
Q2 24
12.8%
0.2%
Q1 24
3.9%
0.2%
Cash Conversion
FVCB
FVCB
OPRX
OPRX
Q4 25
1.41×
Q3 25
1.36×
4.11×
Q2 25
0.58×
2.98×
Q1 25
1.05×
Q4 24
Q3 24
1.00×
Q2 24
0.37×
Q1 24
5.34×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons